Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89035252

CD79A, anti-Human, Clone: IGA/1688R, Abnova™

Catalog No. 89035252 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-035-252 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-035-252 Supplier Abnova Corporation Supplier No. RAB00373
Add to Cart
Add to Cart

Description

Monoclonal Antibody

Sequence: GTYQDVGSLNIADVQ

Specifications

Antigen CD79A
Applications Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone IGA/1688R
Conjugate Unconjugated
Dilution Flow Cytometry (0.5-1 ug/106 cells) Immunofluorescence (0.5-1 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (0.25-0.5 ug/mL) The optimal working dilution should be determined by the end user.
Formulation In 10 mM PBS (0.05% BSA, 0.05% sodium azide).
Gene CD79a molecule, immunoglobulin-associated alpha
Gene Alias IGA/MB-1
Gene Symbols CD79A
Immunogen Original antibody is raised against a synthetic peptide corresponding to amino acids 208-222 of human CD79A.
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 973
Target Species Human
Content And Storage Store at 4°C.
Product Type Antibody
Form Liquid
Isotype IgG κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.